O	0	9	Selective	Selective	JJ	B-NP
O	10	20	inhibition	inhibition	NN	I-NP
O	21	23	of	of	IN	B-PP
O	24	27	the	the	DT	B-NP
B-Organ	28	33	renal	renal	JJ	I-NP
O	34	42	dopamine	dopamine	NN	I-NP
O	43	50	subtype	subtype	NN	I-NP
O	51	54	D1A	D1A	NN	I-NP
O	55	63	receptor	receptor	NN	I-NP
O	64	71	induces	induce	VBZ	B-VP
O	72	87	antinatriuresis	antinatriuresis	NN	B-NP
O	88	90	in	in	IN	B-PP
O	91	100	conscious	conscious	JJ	B-NP
O	101	105	rats	rat	NNS	I-NP
O	105	106	.	.	.	O

O	107	111	Both	Both	CC	O
O	112	120	dopamine	dopamine	NN	B-NP
O	121	123	D1	D1	NN	I-NP
O	123	124	-	-	HYPH	O
O	124	128	like	like	JJ	O
O	129	130	(	(	(	O
O	130	133	D1A	D1A	NN	B-NP
O	134	137	and	and	CC	O
O	138	141	D1B	D1B	NN	B-NP
O	141	142	)	)	)	O
O	143	146	and	and	CC	O
O	147	149	D2	D2	NN	B-NP
O	149	150	-	-	HYPH	O
O	150	154	like	like	JJ	O
O	155	156	(	(	(	O
O	156	158	D2	D2	NN	B-NP
O	158	159	,	,	,	O
O	160	162	D3	D3	NN	B-NP
O	162	163	,	,	,	O
O	164	167	and	and	CC	O
O	168	170	D4	D4	NN	B-NP
O	170	171	)	)	)	O
O	172	180	receptor	receptor	NN	B-NP
O	181	192	subfamilies	subfamily	NNS	I-NP
O	193	196	are	be	VBP	B-VP
O	197	204	present	present	JJ	B-ADJP
O	205	207	in	in	IN	B-PP
O	208	211	the	the	DT	B-NP
B-Organ	212	218	kidney	kidney	NN	I-NP
O	218	219	.	.	.	O

O	220	228	Blockade	Blockade	NN	B-NP
O	229	231	of	of	IN	B-PP
O	232	235	the	the	DT	B-NP
O	236	246	intrarenal	intrarenal	JJ	I-NP
O	247	249	D1	D1	NN	I-NP
O	249	250	-	-	HYPH	B-NP
O	250	254	like	like	JJ	I-NP
O	255	263	receptor	receptor	NN	I-NP
O	264	270	family	family	NN	I-NP
O	271	273	is	be	VBZ	B-VP
O	274	284	associated	associate	VBN	I-VP
O	285	289	with	with	IN	B-PP
O	290	301	natriuresis	natriuresis	NN	B-NP
O	302	305	and	and	CC	I-NP
O	306	314	diuresis	diuresis	NN	I-NP
O	314	315	.	.	.	O

O	316	323	Because	Because	IN	B-SBAR
O	324	327	the	the	DT	B-NP
O	328	331	D1A	D1A	NN	I-NP
O	332	335	and	and	CC	I-NP
O	336	339	D1B	D1B	NN	I-NP
O	340	348	receptor	receptor	NN	I-NP
O	349	357	subtypes	subtype	NNS	I-NP
O	358	361	are	be	VBP	B-VP
O	362	365	not	not	RB	O
O	366	381	distinguishable	distinguishable	JJ	B-ADJP
O	382	384	by	by	IN	B-PP
O	385	394	currently	currently	RB	B-NP
O	395	404	available	available	JJ	I-NP
O	405	417	dopaminergic	dopaminergic	JJ	I-NP
O	418	424	agents	agent	NNS	I-NP
O	424	425	,	,	,	O
O	426	431	their	their	PRP$	B-NP
O	432	442	functional	functional	JJ	I-NP
O	443	447	role	role	NN	I-NP
O	448	455	remains	remain	VBZ	B-VP
O	456	465	undefined	undefined	JJ	B-ADJP
O	465	466	.	.	.	O

O	467	469	In	In	IN	B-PP
O	470	473	the	the	DT	B-NP
O	474	481	present	present	JJ	I-NP
O	482	487	study	study	NN	I-NP
O	487	488	,	,	,	O
O	489	492	the	the	DT	B-NP
O	493	499	effect	effect	NN	I-NP
O	500	502	of	of	IN	B-PP
O	503	512	selective	selective	JJ	B-NP
O	513	523	inhibition	inhibition	NN	I-NP
O	524	526	of	of	IN	B-PP
O	527	530	the	the	DT	B-NP
B-Organ	531	536	renal	renal	JJ	I-NP
O	537	540	D1A	D1A	NN	I-NP
O	541	549	receptor	receptor	NN	I-NP
O	550	554	with	with	IN	B-PP
O	555	572	phosphorothioated	phosphorothioated	JJ	B-NP
O	573	582	antisense	antisense	JJ	I-NP
O	583	603	oligodeoxynucleotide	oligodeoxynucleotide	NN	I-NP
O	604	605	(	(	(	O
O	605	607	AS	AS	NN	B-NP
O	607	608	-	-	HYPH	B-NP
O	608	611	ODN	ODN	NN	I-NP
O	611	612	)	)	)	O
O	613	616	was	be	VBD	B-VP
O	617	629	investigated	investigate	VBN	I-VP
O	630	632	in	in	IN	B-PP
O	633	642	conscious	conscious	JJ	B-NP
O	643	660	uninephrectomized	uninephrectomized	JJ	I-NP
O	661	665	rats	rat	NNS	I-NP
O	665	666	.	.	.	O

O	667	672	After	After	IN	B-PP
B-Immaterial_anatomical_entity	673	678	renal	renal	JJ	B-NP
I-Immaterial_anatomical_entity	679	691	interstitial	interstitial	JJ	I-NP
O	692	706	administration	administration	NN	I-NP
O	707	709	of	of	IN	B-PP
O	710	715	Texas	Texas	NNP	B-NP
O	716	719	red	red	VBD	B-VP
O	719	720	-	-	HYPH	B-NP
O	720	727	labeled	label	VBN	I-NP
O	728	731	D1A	D1A	NN	I-NP
O	732	740	receptor	receptor	NN	I-NP
O	741	743	AS	AS	NN	I-NP
O	743	744	-	-	HYPH	B-NP
O	744	747	ODN	ODN	NN	I-NP
O	747	748	,	,	,	O
O	749	756	intense	intense	JJ	B-NP
O	757	768	fluorescent	fluorescent	JJ	I-NP
O	769	775	signal	signal	NN	I-NP
O	776	779	was	be	VBD	B-VP
O	780	789	localized	localize	VBN	I-VP
O	790	792	in	in	IN	B-PP
O	793	796	the	the	DT	B-NP
B-Tissue	797	802	renal	renal	JJ	I-NP
I-Tissue	803	810	tubular	tubular	JJ	I-NP
I-Tissue	811	821	epithelium	epithelium	NN	I-NP
O	822	825	and	and	CC	I-NP
B-Multi-tissue_structure	826	837	vasculature	vasculature	NN	I-NP
O	837	838	.	.	.	O

O	839	841	In	In	IN	B-PP
O	842	846	rats	rat	NNS	B-NP
O	847	849	on	on	IN	B-PP
O	850	856	normal	normal	JJ	B-NP
O	857	861	salt	salt	NN	I-NP
O	862	868	intake	intake	NN	I-NP
O	868	869	,	,	,	O
O	870	872	AS	AS	NN	B-NP
O	872	873	-	-	HYPH	B-NP
O	873	876	ODN	ODN	NN	I-NP
O	877	885	injected	inject	VBN	B-VP
O	886	900	interstitially	interstitially	RB	B-ADVP
O	901	905	into	into	IN	B-PP
O	906	909	the	the	DT	B-NP
B-Organ	910	916	kidney	kidney	NN	I-NP
O	917	924	reduced	reduce	VBD	B-VP
O	925	930	daily	daily	JJ	B-NP
B-Organism_substance	931	938	urinary	urinary	JJ	I-NP
O	939	945	sodium	sodium	NN	I-NP
O	946	955	excretion	excretion	NN	I-NP
O	956	957	(	(	(	O
O	957	958	1	1	CD	B-NP
O	958	959	.	.	.	O
O	959	960	4	4	CD	B-NP
O	960	961	+	+	SYM	O
O	961	962	/	/	SYM	O
O	962	963	-	-	SYM	B-NP
O	963	964	0	0	CD	B-NP
O	964	965	.	.	SYM	I-NP
O	965	967	04	04	CD	I-NP
O	968	974	versus	versus	IN	B-PP
O	975	976	0	0	CD	B-NP
O	976	977	.	.	.	O
O	977	978	8	8	CD	B-NP
O	978	979	+	+	SYM	O
O	979	980	/	/	SYM	O
O	980	981	-	-	SYM	B-NP
O	981	982	0	0	CD	B-NP
O	982	983	.	.	SYM	I-NP
O	983	984	2	2	CD	I-NP
O	985	988	mEq	mEq	NN	I-NP
O	988	989	/	/	SYM	B-NP
O	989	990	d	d	NN	B-NP
O	990	991	,	,	,	O
O	992	993	n	n	NN	B-NP
O	993	994	=	=	SYM	B-VP
O	994	995	5	5	CD	B-NP
O	995	996	,	,	,	O
O	997	998	P	P	NN	B-NP
O	998	999	<	<	SYM	B-VP
O	999	1000	0	0	CD	B-NP
O	1000	1001	.	.	.	I-NP
O	1001	1003	05	05	CD	I-NP
O	1003	1004	)	)	)	O
O	1005	1008	and	and	CC	O
B-Organism_substance	1009	1014	urine	urine	NN	B-NP
O	1015	1021	output	output	NN	I-NP
O	1022	1023	(	(	(	O
O	1023	1025	16	16	CD	B-NP
O	1025	1026	.	.	.	O
O	1026	1027	9	9	CD	B-NP
O	1027	1028	+	+	SYM	O
O	1028	1029	/	/	SYM	B-NP
O	1029	1030	-	-	SYM	B-NP
O	1030	1031	3	3	CD	I-NP
O	1031	1032	.	.	SYM	I-NP
O	1032	1033	8	8	CD	I-NP
O	1034	1040	versus	versus	IN	I-NP
O	1041	1043	12	12	CD	I-NP
O	1043	1044	.	.	.	I-NP
O	1044	1045	5	5	CD	I-NP
O	1045	1046	+	+	SYM	B-NP
O	1046	1047	/	/	SYM	B-VP
O	1047	1048	-	-	SYM	B-NP
O	1048	1049	3	3	CD	I-NP
O	1049	1050	.	.	SYM	I-NP
O	1050	1051	6	6	CD	I-NP
O	1052	1054	mL	mL	NN	I-NP
O	1054	1055	/	/	SYM	I-NP
O	1055	1056	d	d	NN	I-NP
O	1056	1057	,	,	,	O
O	1058	1059	n	n	NN	B-NP
O	1059	1060	=	=	SYM	B-VP
O	1060	1061	5	5	CD	B-NP
O	1061	1062	,	,	,	O
O	1063	1064	P	P	NN	B-NP
O	1064	1065	<	<	SYM	B-VP
O	1065	1066	0	0	CD	B-NP
O	1066	1067	.	.	.	I-NP
O	1067	1069	05	05	CD	I-NP
O	1069	1070	)	)	)	O
O	1070	1071	.	.	.	O

O	1072	1074	In	In	IN	B-PP
O	1075	1079	rats	rat	NNS	B-NP
O	1080	1082	on	on	IN	B-PP
O	1083	1087	high	high	JJ	B-NP
O	1088	1094	sodium	sodium	NN	I-NP
O	1095	1101	intake	intake	NN	I-NP
O	1101	1102	,	,	,	O
O	1103	1113	continuous	continuous	JJ	B-NP
B-Immaterial_anatomical_entity	1114	1119	renal	renal	JJ	I-NP
I-Immaterial_anatomical_entity	1120	1132	interstitial	interstitial	JJ	I-NP
O	1133	1147	administration	administration	NN	I-NP
O	1148	1150	of	of	IN	B-PP
O	1151	1154	D1A	D1A	NN	B-NP
O	1155	1163	receptor	receptor	NN	I-NP
O	1164	1166	AS	AS	NN	I-NP
O	1166	1167	-	-	HYPH	O
O	1167	1170	ODN	ODN	NN	B-NP
O	1171	1182	transiently	transiently	RB	B-ADVP
O	1183	1192	decreased	decrease	VBD	B-VP
O	1193	1198	daily	daily	JJ	B-NP
B-Organism_substance	1199	1206	urinary	urinary	JJ	I-NP
O	1207	1213	sodium	sodium	NN	I-NP
O	1214	1223	excretion	excretion	NN	I-NP
O	1224	1225	(	(	(	O
O	1225	1226	5	5	CD	B-NP
O	1226	1227	.	.	.	O
O	1227	1228	4	4	CD	B-NP
O	1228	1229	+	+	SYM	O
O	1229	1230	/	/	SYM	O
O	1230	1231	-	-	SYM	B-NP
O	1231	1232	0	0	CD	B-NP
O	1232	1233	.	.	SYM	I-NP
O	1233	1234	5	5	CD	I-NP
O	1235	1241	versus	versus	IN	B-PP
O	1242	1243	4	4	CD	B-NP
O	1243	1244	.	.	.	I-NP
O	1244	1245	2	2	CD	I-NP
O	1245	1246	+	+	SYM	B-NP
O	1246	1247	/	/	SYM	I-NP
O	1247	1248	-	-	SYM	I-NP
O	1248	1249	0	0	CD	I-NP
O	1249	1250	.	.	SYM	I-NP
O	1250	1251	3	3	CD	I-NP
O	1252	1255	mEq	mEq	NN	I-NP
O	1255	1256	/	/	SYM	O
O	1256	1257	d	d	NN	B-NP
O	1257	1258	,	,	,	O
O	1259	1260	n	n	NN	B-NP
O	1260	1261	=	=	SYM	B-VP
O	1261	1262	7	7	CD	B-NP
O	1262	1263	,	,	,	O
O	1264	1265	P	P	NN	B-NP
O	1265	1266	<	<	SYM	B-VP
O	1266	1267	0	0	CD	B-NP
O	1267	1268	.	.	.	I-NP
O	1268	1270	01	01	CD	I-NP
O	1270	1271	)	)	)	O
O	1272	1275	and	and	CC	O
B-Organism_substance	1276	1281	urine	urine	NN	B-NP
O	1282	1288	output	output	NN	I-NP
O	1289	1290	(	(	(	O
O	1290	1292	27	27	CD	B-NP
O	1292	1293	.	.	.	O
O	1293	1294	6	6	CD	B-NP
O	1294	1295	+	+	SYM	B-NP
O	1295	1296	/	/	SYM	I-NP
O	1296	1297	-	-	SYM	I-NP
O	1297	1298	4	4	CD	I-NP
O	1298	1299	.	.	SYM	I-NP
O	1299	1300	5	5	CD	I-NP
O	1301	1307	versus	versus	IN	B-PP
O	1308	1310	18	18	CD	B-NP
O	1310	1311	.	.	.	I-NP
O	1311	1312	1	1	CD	I-NP
O	1312	1313	+	+	SYM	O
O	1313	1314	/	/	SYM	O
O	1314	1315	-	-	SYM	B-NP
O	1315	1316	1	1	CD	I-NP
O	1316	1317	.	.	SYM	I-NP
O	1317	1318	8	8	CD	I-NP
O	1319	1321	mL	mL	NN	I-NP
O	1321	1322	/	/	SYM	O
O	1322	1323	d	d	NN	B-NP
O	1323	1324	,	,	,	O
O	1325	1326	n	n	NN	B-NP
O	1326	1327	=	=	SYM	B-VP
O	1327	1328	7	7	CD	B-NP
O	1328	1329	,	,	,	O
O	1330	1331	P	P	NN	B-NP
O	1331	1332	<	<	SYM	B-VP
O	1332	1333	0	0	CD	B-NP
O	1333	1334	.	.	.	I-NP
O	1334	1336	01	01	CD	I-NP
O	1336	1337	)	)	)	O
O	1337	1338	.	.	.	O

O	1339	1346	Neither	Neither	CC	O
O	1347	1354	vehicle	vehicle	NN	B-NP
O	1355	1358	nor	nor	CC	O
O	1359	1364	sense	sense	NN	B-NP
O	1365	1385	oligodeoxynucleotide	oligodeoxynucleotide	NN	I-NP
O	1386	1389	had	have	VBD	B-VP
O	1390	1401	significant	significant	JJ	B-NP
O	1402	1409	effects	effect	NNS	I-NP
O	1409	1410	.	.	.	O

O	1411	1419	Systolic	Systolic	JJ	B-NP
B-Organism_substance	1420	1425	blood	blood	NN	I-NP
O	1426	1434	pressure	pressure	NN	I-NP
O	1435	1443	remained	remain	VBD	B-VP
O	1444	1453	unchanged	unchanged	JJ	B-ADJP
O	1453	1454	.	.	.	O

O	1455	1458	The	The	DT	B-NP
B-Organ	1459	1464	renal	renal	JJ	I-NP
O	1465	1468	D1A	D1A	NN	I-NP
O	1469	1477	receptor	receptor	NN	I-NP
O	1478	1485	protein	protein	NN	I-NP
O	1486	1489	was	be	VBD	B-VP
O	1490	1503	significantly	significantly	RB	I-VP
O	1504	1513	decreased	decrease	VBN	I-VP
O	1514	1516	by	by	IN	B-PP
O	1517	1519	35	35	CD	B-NP
O	1519	1520	%	%	NN	I-NP
O	1521	1524	and	and	CC	O
O	1525	1527	46	46	CD	B-NP
O	1527	1528	%	%	NN	I-NP
O	1529	1531	at	at	IN	B-PP
O	1532	1535	the	the	DT	B-NP
O	1536	1539	end	end	NN	I-NP
O	1540	1542	of	of	IN	B-PP
O	1543	1546	the	the	DT	B-NP
O	1547	1552	study	study	NN	I-NP
O	1553	1555	in	in	IN	B-PP
O	1556	1558	AS	AS	NN	B-NP
O	1558	1559	-	-	HYPH	B-NP
O	1559	1562	ODN	ODN	NN	I-NP
O	1562	1563	-	-	HYPH	B-NP
O	1563	1570	treated	treat	VBN	I-NP
O	1571	1575	rats	rat	NNS	I-NP
O	1576	1578	on	on	IN	B-PP
O	1579	1585	normal	normal	JJ	B-NP
O	1586	1589	and	and	CC	I-NP
O	1590	1594	high	high	JJ	I-NP
O	1595	1599	salt	salt	NN	I-NP
O	1600	1606	intake	intake	NN	I-NP
O	1606	1607	,	,	,	O
O	1608	1620	respectively	respectively	RB	B-ADVP
O	1620	1621	,	,	,	O
O	1622	1629	whereas	whereas	IN	O
O	1630	1633	the	the	DT	B-NP
O	1634	1637	D1B	D1B	NN	I-NP
O	1638	1646	receptor	receptor	NN	I-NP
O	1647	1650	and	and	CC	O
O	1651	1655	beta	beta	SYM	O
O	1655	1656	-	-	HYPH	O
O	1656	1661	actin	actin	NN	B-NP
O	1662	1666	were	be	VBD	B-VP
O	1667	1670	not	not	RB	I-VP
O	1671	1679	affected	affect	VBN	I-VP
O	1679	1680	.	.	.	O

O	1681	1686	These	These	DT	B-NP
O	1687	1694	results	result	NNS	I-NP
O	1695	1702	provide	provide	VBP	B-VP
O	1703	1706	the	the	DT	B-NP
O	1707	1712	first	first	JJ	I-NP
O	1713	1719	direct	direct	JJ	I-NP
O	1720	1728	evidence	evidence	NN	I-NP
O	1729	1733	that	that	IN	B-SBAR
O	1734	1737	the	the	DT	B-NP
B-Organ	1738	1743	renal	renal	JJ	I-NP
O	1744	1747	D1A	D1A	NN	I-NP
O	1748	1756	receptor	receptor	NN	I-NP
O	1757	1764	subtype	subtype	NN	I-NP
O	1765	1770	plays	play	VBZ	B-VP
O	1771	1773	an	an	DT	B-NP
O	1774	1783	important	important	JJ	I-NP
O	1784	1788	role	role	NN	I-NP
O	1789	1791	in	in	IN	B-PP
O	1792	1795	the	the	DT	B-NP
O	1796	1803	control	control	NN	I-NP
O	1804	1806	of	of	IN	B-PP
O	1807	1813	sodium	sodium	NN	B-NP
O	1814	1823	excretion	excretion	NN	I-NP
O	1823	1824	.	.	.	O

